Diclofenac Sodium and Lidocaine Hydrochloride Injection: A Potent Pharmaceutical Grade Analgesic and Amide Local Anesthetic
Diclofenac Sodium and Lidocaine Hydrochloride Injection is a pharmaceutical grade product developed to provide potent relief from varying degrees of pain. Primarily acting as a non-steroidal anti-inflammatory drug (NSAID), it works efficiently in reducing pain and inflammation with an added benefit of local anesthesia, offered by Lidocaine Hydrochloride.
- It contains Diclofenac Sodium, a drug used for its potent anti-inflammatory and analgesic properties. Lidocaine Hydrochloride, on the other hand, acts as an amide local anesthetic that provides temporary numbness or loss of sensation in the area where injected.
- Molecular Formula of Diclofenac Sodium: C14H10Cl2NNaO2 and Lidocaine Hydrochloride: C14H22N2O. It ensures the correct proportion of all components, leading to effective relief from pain and inflammation.
- LD50 of Diclofenac Sodium in rats: oral > 1700 mg/kg and Lidocaine Hydrochloride in mouse: oral > 300 mg/kg indicating considerable safety margins.
- Hazard and Precautionary Statements: Non-usage in patients with acute porphyria and hypersensitivity to the components of the injection. Caution required in patients with severe hepatic, cardiac, or renal insufficiency, epilepsy, and in the elderly.
- Therapeutic Uses include analgesic, antipyretic, dysmenorrhea, osteoarthritis, and rheumatoid arthritis.
- Possible side effects may include gastrointestinal bleedings, skin reactions, abnormal liver function, renal function impairment.
Made with precision in Jining, Shandong, China, this pharmaceutical-grade product caters to a diverse geographical market, ranging from North America to Western Europe, Central/South America, Asia, Middle East, Australasia, and Africa.